1029714-88-2 Usage
Description
2-Fluoro-4-(7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl)benzoic acid is a complex and highly specific chemical compound with potential pharmaceutical applications. It features a benzene ring with a fluorine and a carboxylic acid functional group, as well as a quinoline and imidazole subunit. The combination of these chemical features suggests that it may have the ability to modulate biological pathways or interact with specific proteins.
Uses
Used in Pharmaceutical Research:
2-Fluoro-4-(7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl)benzoic acid is used as a potential therapeutic agent for treating certain diseases or conditions. Its unique structure allows it to potentially modulate biological pathways or interact with specific proteins, making it a candidate for further investigation in the field of pharmaceuticals.
Used in Biochemical Research:
2-Fluoro-4-(7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl)benzoic acid is used as a chemical tool in biochemical research to study the interactions between compounds and biological systems. Its specific chemical features may provide insights into the mechanisms of action and potential applications in understanding complex biological processes.
Check Digit Verification of cas no
The CAS Registry Mumber 1029714-88-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,9,7,1 and 4 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1029714-88:
(9*1)+(8*0)+(7*2)+(6*9)+(5*7)+(4*1)+(3*4)+(2*8)+(1*8)=152
152 % 10 = 2
So 1029714-88-2 is a valid CAS Registry Number.
1029714-88-2Relevant articles and documents
Preparation method of capmatinib
-
Paragraph 0040-0042, (2020/11/09)
The invention provides a preparation method of capmatinib. The inventor carries out wide and deep research, massive screening and testing. A compound represented by a formula III is adopted as the rawmaterial for hydrolysis reaction and methylation reaction to obtain a formula I compound, namely capmatinib. The method is mild in reaction condition, environment-friendly, low in energy consumption,good in product purity and high in yield, and is suitable for industrial large-scale production.
Deuterated Capmatinib compounds and uses thereof
-
Paragraph 0052; 0063-0064, (2019/12/25)
The invention discloses deuterated Capmatinib compounds and uses thereof, in particular to compounds represented by formula (I) or optical isomers, pharmaceutically acceptable salts, hydrate or solvate thereof, wherein R1-R16 is independently selected fro
IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS KINASE INHIBITORS
-
Page/Page column 45, (2008/12/05)
-
